Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€8.47
13.12.21
-
13.12.22
-67.06%
14.12.22

Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.62
02.12.21
-
02.12.22
45.82%
12.12.21

Risky Investment
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€4.85
01.12.21
-
01.12.22
-53.67%
02.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.96
01.12.21
€6.00
01.12.22
-2.70%
11.12.21

Could be worthwhile Investment >10% per year
Innovative
Good culture
Below average Management
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€39.25
30.11.21
-
30.11.22
-17.83%
12.12.21

Probably not worthwhile Investment
buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.22
29.11.21
-
29.11.22
-16.11%
12.12.21

Could be worthwhile Investment >10% per year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.00
28.11.21
-
28.11.22
7.65%
11.12.21

Could be worthwhile Investment >10% per year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.50
22.11.21
-
22.11.22
-2.83%
28.11.21

Risky Investment
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€46.25
17.11.21
€37.50
30.11.22
-19.46%
18.11.21

Could be very worthwhile Investment >20% year
buy
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.75
17.11.21
€50.00
17.11.22
4.64%
27.11.21

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€23.97
15.11.21
-
15.11.22
-28.16%
26.11.21

Could be worthwhile Investment >10% per year
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€13.55
13.11.21
-
13.11.22
-69.88%
14.11.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€25.86
27.10.21
€40.00
31.12.23
-59.32%
08.05.23

Could be very worthwhile Investment >20% year
buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.45
18.10.21
€12.00
31.12.23
-2.68%
08.05.23

Could be very worthwhile Investment >20% year
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.87
13.10.21
€10.00
13.10.24
-4.83%
15.06.22

Leading role in innovation
Capable Management
Good culture
Strong uniques
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.88
13.10.21
€8.50
13.10.22
-1.14%
13.10.21

Leading role in innovation
Capable Management
Good culture
Strong uniques
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.95
10.10.21
€8.00
31.12.23
58.11%
13.12.21

Could be very worthwhile Investment >20% year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.49
10.10.21
€5.00
31.12.23
-32.83%
08.05.23

Could be very worthwhile Investment >20% year
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.00
05.10.21
-
05.10.22
-10.00%
08.12.21

Probably not worthwhile Investment
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€19.92
28.09.21
-
28.09.22
-6.85%
02.10.21

Could be worthwhile Investment >10% per year
buy
Ceapro Inc

Start price
Target price
Perf. (%)
€0.41
27.09.21
€0.88
27.09.24
-
27.02.24

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.79
20.09.21
-
20.09.25
-26.16%
03.04.23

Could be worthwhile Investment >10% per year
buy
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€8.53
20.09.21
-
20.09.22
-27.86%
02.10.21

Could be worthwhile Investment >10% per year
Capable Management
Little innovation
Burcon Nutrascience Corp.

Start price
Target price
Perf. (%)
€1.53
19.09.21
-
19.09.22
-75.74%
20.09.22

Probably not worthwhile Investment
buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.20
18.09.21
€40.00
31.12.23
61.97%
16.12.21

Could be very worthwhile Investment >20% year